Progyny, Inc. to Present at BofA Securities 2024 Healthcare Conference and Leerink Partners Healthcare Crossroads Conference 2024

NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives will participate in a

GlobeNewswireMay 14 23:00

Analysts' Top Healthcare Picks: Xenon (XENE), Progyny (PGNY)

TipRanksMay 14 20:30

Progyny Price Target Cut to $30.00/Share From $48.00 by Barclays

Progyny Price Target Cut to $30.00/Share From $48.00 by Barclays

Dow JonesMay 14 02:05

Progyny Is Maintained at Overweight by Barclays

Progyny Is Maintained at Overweight by Barclays

Dow JonesMay 14 02:05

Barclays Maintains Overweight on Progyny, Lowers Price Target to $30

Barclays analyst Sarah James maintains Progyny (NASDAQ:PGNY) with a Overweight and lowers the price target from $48 to $30.

BenzingaMay 14 01:54

Progyny (NASDAQ:PGNY) Has More To Do To Multiply In Value Going Forward

Yahoo FinanceMay 13 18:31